Eton Pharmaceuticals' (ETON) CEO Sean Brynjelsen on Q1 2019 Results - Earnings Conference Call [Seeking Alpha]
Eton Pharmaceuticals, Inc. (ETON)
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
Eton Pharmaceuticals' (ETON) CEO Sean Brynjelsen on Q1 2019 Results - Earnings Conference Call Eton Pharmaceuticals, Inc. (NASDAQ: ETON Company Participants David Krempa – Vice President-Business Development Sean Brynjelsen – Chief Executive Officer Wilson Troutman – Chief Financial Officer Conference Call Participants Andrew D'silva – B.Riley Ram Selvaraju – H.C. Wainwright Brett Conrad – Longboard Capital Robert London – London Family Trust Operator Good afternoon and welcome to the Eton Pharmaceuticals First Quarter 2019 Financial and Operating Results Conference Call. At this time, all participants are in a listen only mode. Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the Company's request. At this time, I'd like to turn it over to David Krempa, Vice President of Business Development at Eton pharmaceuticals. Please proceed. Thank you operator. Good afternoon and welcome to Eton's first quarter 201
Show less
Read more
Impact Snapshot
Event Time:
ETON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ETON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ETON alerts
High impacting Eton Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ETON
News
- Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE [Yahoo! Finance]Yahoo! Finance
- Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria [Yahoo! Finance]Yahoo! Finance
- Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for PhenylketonuriaGlobeNewswire
- Harrow Health Non-GAAP EPS of -$0.20 misses by $0.15, revenue of $36.36M misses by $1.5M [Seeking Alpha]Seeking Alpha
- Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
ETON
Earnings
- 3/14/24 - Miss
ETON
Sec Filings
- 4/18/24 - Form 8-K
- 3/26/24 - Form S-8
- 3/22/24 - Form 10-K/A
- ETON's page on the SEC website